Compass Therapeutics Inc. (NASDAQ: CMPX)
$1.04
+0.0300 ( +2.97% ) 368.3K
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.
Market Data
Open
$1.04
Previous close
$1.01
Volume
368.3K
Market cap
$144.47M
Day range
$1.02 - $1.11
52 week range
$0.77 - $3.01
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Jan 05, 2024 |
4 | Insider transactions | 1 | Nov 21, 2023 |
4 | Insider transactions | 1 | Nov 21, 2023 |
8-k | 8K-related | 14 | Nov 09, 2023 |
10-q | Quarterly Reports | 62 | Nov 09, 2023 |
10-q | Quarterly Reports | 62 | Aug 03, 2023 |
8-k | 8K-related | 14 | Aug 03, 2023 |